Luye Pharma Group Ltd. (HKG:2186)
Hong Kong
· Delayed Price · Currency is HKD 2.660
-0.030 (-1.12%)
Apr 29, 2026, 4:08 PM HKT
Luye Pharma Group Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | - | 471.89 | 532.61 | 604.81 | -134.39 | Upgrade
|
| Depreciation & Amortization | - | 783.39 | 693.73 | 663.46 | 577 | Upgrade
|
| Other Amortization | - | 7.28 | 8.12 | 7.86 | 4.99 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -18.49 | -1.5 | 0.21 | -11.36 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 11.47 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -1.79 | -1.94 | -1.55 | 14.81 | Upgrade
|
| Loss (Gain) on Equity Investments | - | 0.77 | -0.79 | -0.83 | -10.27 | Upgrade
|
| Stock-Based Compensation | - | 21.5 | 20.64 | 25.45 | 49.98 | Upgrade
|
| Other Operating Activities | - | 136.97 | -53.37 | 23.14 | 109.71 | Upgrade
|
| Change in Accounts Receivable | - | -424.88 | -570.84 | -18.77 | -211.76 | Upgrade
|
| Change in Inventory | - | -84.03 | -54.92 | -26.6 | -134.04 | Upgrade
|
| Change in Accounts Payable | - | -77.89 | 207.24 | -10.95 | 43.64 | Upgrade
|
| Change in Unearned Revenue | - | 9.97 | -74.87 | -42.47 | -6.43 | Upgrade
|
| Change in Other Net Operating Assets | - | -656.92 | 891.38 | 418.57 | -109.49 | Upgrade
|
| Operating Cash Flow | - | 167.76 | 1,595 | 1,654 | 182.37 | Upgrade
|
| Operating Cash Flow Growth | - | -89.48% | -3.53% | 806.83% | -82.35% | Upgrade
|
| Capital Expenditures | - | -594.07 | -632.66 | -655.68 | -556.2 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 7.44 | 3.17 | 5.66 | 13.77 | Upgrade
|
| Divestitures | - | -0.02 | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | -1,113 | -532.61 | -507.68 | -985.4 | Upgrade
|
| Investment in Securities | - | 536.35 | -511.14 | -675.93 | -2,057 | Upgrade
|
| Other Investing Activities | - | 162.36 | 254.97 | 175.32 | 148.46 | Upgrade
|
| Investing Cash Flow | - | -1,471 | -1,418 | -1,658 | -3,436 | Upgrade
|
| Short-Term Debt Issued | - | - | 4.96 | 10.1 | - | Upgrade
|
| Long-Term Debt Issued | - | 10,119 | 8,077 | 7,656 | 7,155 | Upgrade
|
| Total Debt Issued | - | 10,119 | 8,082 | 7,666 | 7,155 | Upgrade
|
| Short-Term Debt Repaid | - | - | -15.06 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -8,263 | -8,555 | -8,323 | -7,561 | Upgrade
|
| Total Debt Repaid | - | -8,263 | -8,570 | -8,323 | -7,561 | Upgrade
|
| Net Debt Issued (Repaid) | - | 1,856 | -488.07 | -656.23 | -406.32 | Upgrade
|
| Issuance of Common Stock | - | - | 922.97 | - | 1,044 | Upgrade
|
| Other Financing Activities | - | 1,101 | 406.7 | 710.38 | 1,241 | Upgrade
|
| Financing Cash Flow | - | 2,956 | 841.6 | 54.15 | 1,879 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 45.41 | -103.6 | -164.15 | -52.37 | Upgrade
|
| Net Cash Flow | - | 1,698 | 915.23 | -114.51 | -1,427 | Upgrade
|
| Free Cash Flow | - | -426.31 | 962.83 | 998.11 | -373.83 | Upgrade
|
| Free Cash Flow Growth | - | - | -3.54% | - | - | Upgrade
|
| Free Cash Flow Margin | - | -7.03% | 15.67% | 16.69% | -7.19% | Upgrade
|
| Free Cash Flow Per Share | - | -0.11 | 0.26 | 0.29 | -0.11 | Upgrade
|
| Cash Interest Paid | - | 450.1 | 471.51 | 369.2 | 297.12 | Upgrade
|
| Cash Income Tax Paid | - | 206.93 | 132.23 | 92.77 | 270.74 | Upgrade
|
| Levered Free Cash Flow | - | -2,501 | 629.06 | -43 | -778.54 | Upgrade
|
| Unlevered Free Cash Flow | - | -2,150 | 1,051 | 251.85 | -528.88 | Upgrade
|
| Change in Working Capital | - | -1,234 | 397.99 | 319.79 | -418.08 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.